MedPacto Inc
MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea.
MedPacto Inc (235980) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.093x
Based on the latest financial reports, MedPacto Inc (235980) has a cash flow conversion efficiency ratio of -0.093x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.51 Billion) by net assets (₩48.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
MedPacto Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how MedPacto Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
MedPacto Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedPacto Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DMS Co.Ltd
KQ:068790
|
0.056x |
|
Indo Borax & Chemicals Limited
NSE:INDOBORAX
|
0.003x |
|
Pelican Acquisition Corporation Ordinary Shares
NASDAQ:PELI
|
-0.004x |
|
Envela Corp
NYSE MKT:ELA
|
0.039x |
|
Prospect Resources Ltd
AU:PSC
|
-0.051x |
|
INVICTA HLDGS RC-05
F:I5J
|
N/A |
|
Cemindo Gemilang Tbk PT
JK:CMNT
|
0.068x |
|
Summit Midstream Corporation
NYSE:SMC
|
0.024x |
Annual Cash Flow Conversion Efficiency for MedPacto Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of MedPacto Inc from 2017 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩57.74 Billion | ₩-16.56 Billion | -0.287x | +22.69% |
| 2023-12-31 | ₩70.91 Billion | ₩-26.30 Billion | -0.371x | +59.52% |
| 2022-12-31 | ₩32.32 Billion | ₩-29.61 Billion | -0.916x | -58.60% |
| 2021-12-31 | ₩43.54 Billion | ₩-25.15 Billion | -0.578x | -37.72% |
| 2020-12-31 | ₩55.74 Billion | ₩-23.38 Billion | -0.419x | -117.10% |
| 2019-12-31 | ₩78.69 Billion | ₩-15.20 Billion | -0.193x | +89.10% |
| 2018-12-31 | ₩4.58 Billion | ₩-8.12 Billion | -1.773x | -778.45% |
| 2017-12-31 | ₩-10.29 Billion | ₩-2.69 Billion | 0.261x | -- |